“Aspects of Regulatory Requirements in Industrialized Countries”

Abstract

Compliance with regulatory requirements of major foreign markets for health registration of pharmaceutical products is a continuing challenge for the multinational pharmaceutical company operating from the United States. Highlights of four sample countries, France, Germany and the U.K. are reviewed.